Wade Self, Ph.D. Email & Phone Number
Who is Wade Self, Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Wade Self, Ph.D. is listed as Postdoctoral Research Scholar at Washington University School of Medicine in St. Louis, based in St Louis, Missouri, United States. AeroLeads shows a matched LinkedIn profile for Wade Self, Ph.D..
Wade Self, Ph.D. previously worked as Instructor at Washington University School Of Medicine In St. Louis and Postdoctoral Research Associate at Washington University School Of Medicine In St. Louis. Wade Self, Ph.D. holds Doctor Of Philosophy (Ph.D.), Neuroscience from Washington University School Of Medicine In St. Louis.
Email format at Washington University School of Medicine in St. Louis
This section adds company-level context without repeating Wade Self, Ph.D.'s masked contact details.
Review company-level records connected to Wade Self, Ph.D. before choosing the right outreach path.
About Wade Self, Ph.D.
As a Research-track Faculty Member at Washington University School of Medicine in St. Louis (WUSM), I lead a translational research team that aims to understand the mechanisms by which gut microbiota contribute to Alzheimer Disease pathogenesis and to develop novel therapeutic approaches. I have a PhD in Biology and Biomedical Sciences from WUSM and over 10 years of scientific experience in neurodegeneration research.My expertise spans multiple therapeutic areas including: Alzheimer, Parkinson, ALS, PSP, FTD, and MS, utilizing modalities including: monoclonal antibodies, RNA-targeting oligonucleotides, small molecules, medical devices, and manipulation of the gut microbiome for therapeutic intervention. I am an effective communicator of complex scientific topics, with multiple publications, presentations, and awards, and an extensive network of industry researchers, academic experts, and clinical key opinion leaders in neurology. I have a collaborative yet strategic mindset for solving challenging problems in drug development, built from experiences in life sciences consulting and venture capital. My mission is to advance the understanding and treatment of neurodegenerative diseases to improve the lives of patients and their families.
Wade Self, Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Wade Self, Ph.D. work experience
A career timeline built from the work history available for this profile.
Instructor
Current
Postdoctoral Research Associate
• Scholar under the mentorship of Dr. David Holtzman• Leading a translational research team that aims to understand the mechanisms by which gut microbiota contribute to Alzheimer Disease pathogenesis utilizing transgenic mouse models, raised in specific pathogen free and gnotobiotic conditions, and human fecal samples from individuals living with AD.• Leading a collaboration with a biotechnology company to understand how experimental therapeutics modify AD-associated pathologies in transgenic mouse models.
Postdoctoral Scholar
• Led a research team to identify the mechanisms by which the gut microbiome influences the onset and progression of Alzheimer’s Disease pathology in transgenic animal models under the mentorship of Dr. Sangram Sisodia.• Collaborated with a pre-market pharmaceutical company to test small molecules which target the peripheral immune system in preclinical models of Alzheimer’s Disease.
Postdoctoral Research Fellow
• Led the ideation and development of new target-binding and pharmacodynamics biomarker assays for therapeutics targeting tau protein in Alzheimer’s Disease and Primary Tauopathies• Developed personal relationships with biomarker scientists and senior leadership within DMPK and Clinical Development at Ludwigshafen, Germany and North Chicago, Illinois to more efficiently drive tau biomarker projects towards clinical development in compliance with FDA guidance• Communicateed science in biomarker method validation reports and presentations at scientific conferences• Identified and initiated experimental collaborations with key tau biology scientific leaders within AbbVie Discovery Neuroscience at Cambridge, Massachusetts to generate key data for preclinical candidate nomination• Served as an AbbVie project representative for the Center for Protein Therapeutics at SUNY-Buffalo to provide scientific consultation and communicate project team research findings to DMPK leadership• Led event planning and identification of learning development opportunities for AbbVie Postdoctoral Research Fellows as the AbbVie Postdoctoral Program Education Committee Chair
President And Co-Founder
• Led team of mobile application developers and teachers to design and create products for middle school STEM classrooms focused on neuroscience and brain education. Piloted prototype material with 200+ students in St. Louis Public School Districts. • Developed profitable business model (33% Profit Margin) that connects students to subject-matter experts for online learning.
Analyst
• Performed primary interviews with therapeutic area key opinion leaders and prepared investments reports to analyze prospective medical device and biotechnology companies for seed-stage investment • Researched emerging trends and innovative technologies in the pharmaceutical, biotechnology, and health care information technology industry to identify potential investment leads
Tl1 Clinical Research Program Fellow
• Awarded $90,000 in funding over 3 years for training in clinical and translational science through research, didactic coursework, works in progress research discussions, journal clubs, and presentations at conferences (3). • Relevant Coursework: Drug and Device Development, Statistics for Clinical Research, Designing Outcomes for Clinical Research • Clinical Research Training Center Outstanding Citizenship Award, May 2017, awarded to one student in the TL1 Predoctoral Clinical Research Fellowship in recognition of outstanding achievement in the program
Doctoral Candidate
• Thesis Advisors included Dr. Timothy Miller, a world leader in amyotrophic lateral sclerosis drug development, and Dr. Randall Bateman, a world leader in clinical Alzheimer's Disease investigations.• Communicated research in amyotrophic lateral sclerosis drug development through scientific publication in high-impact journals (3), presentations at international conferences (6), and authoring grants totaling $1,500,000+ for the laboratory• Managed a cross-functional team of R&D scientists at two biotechnology companies, scientists in 3 academic research groups, and clinical research coordinators at 2 medical centers to perform a clinical study in human ALS patients (NCT03449212) • Developed protein-based biomarkers in cerebrospinal fluid to assay pharmacodynamics of RNA-targeted therapies for ALS and Alzheimer disease
Director Of Operations, Project Manager
• Guided organizational strategy and personally mentored 20+ consultants and project managers over 6 engagements• Primary manager of company website, project management software, and document curation for 40+ consulting projects • Created new standardized processes for all project managers to increase efficiency organization-wide, including novel feedback mechanisms for consultants and time management tools to monitor weekly team member workload • Managed five-person teams of PhD scientists across multiple scientific disciplines by designing research objectives, organizing and leading team meetings, and communicating with clients across 4 projects• Completed 2 projects in go-to-market business strategy for clients in pharmaceutical drug development (neurology, antimicrobial)
Teaching Assistant
• BME 105: Introduction to Biomedical Engineering • Held office hours for student questions and review of course material
Undergraduate Research Assistant
• Volunteer Undergraduate Researcher in the Laboratory of Dr. Jeffrey Capadona in the Department of Biomedical Engineering. • Investigated modulators of chronic neuroinflammation associated with intracortical microelectrode implantation for functional electrical stimulation (FES).• Authored 2 scientific publications and received research fellowship grants at CWRU and the Mayo Clinic Totaling $10,000
Summer Undergraduate Research Fellow
• Fellow in the laboratory of Dr. Guojun Bu, Ph.D. in the Department of Molecular Neuroscience. • Project focused on identifying natural compounds that modulate Apolipoprotein E production in astrocytes.
Wade Self, Ph.D. education
Doctor Of Philosophy (Ph.D.), Neuroscience
Bachelor Of Science (Bs), Magna Cum Laude, Biomedical/Medical Engineering
High School Diploma
Frequently asked questions about Wade Self, Ph.D.
Quick answers generated from the profile data available on this page.
What company does Wade Self, Ph.D. work for?
Wade Self, Ph.D. works for Washington University School of Medicine in St. Louis.
What is Wade Self, Ph.D.'s role at Washington University School of Medicine in St. Louis?
Wade Self, Ph.D. is listed as Postdoctoral Research Scholar at Washington University School of Medicine in St. Louis.
Where is Wade Self, Ph.D. based?
Wade Self, Ph.D. is based in St Louis, Missouri, United States while working with Washington University School of Medicine in St. Louis.
What companies has Wade Self, Ph.D. worked for?
Wade Self, Ph.D. has worked for Washington University School Of Medicine In St. Louis, University Of Chicago, Abbvie, Pocket Phd'S Inc., and Cultivation Capital.
How can I contact Wade Self, Ph.D.?
You can use AeroLeads to view verified contact signals for Wade Self, Ph.D. at Washington University School of Medicine in St. Louis, including work email, phone, and LinkedIn data when available.
What schools did Wade Self, Ph.D. attend?
Wade Self, Ph.D. holds Doctor Of Philosophy (Ph.D.), Neuroscience from Washington University School Of Medicine In St. Louis.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial